BIO Top Priority Is Medicare Reimbursement Negotiations, Chairman Says

Negotiating appropriate Medicare reimbursement rates is one of the Biotechnology Industry Organization's top priorities over the next two years, Alkermes CEO and BIO Chairman Richard Pops said Feb. 25